Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.47 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent COAG insider activity includes RA CAPITAL MANAGEMENT, L.P. bought 6.39K, RA CAPITAL MANAGEMENT, L.P. bought 14.15K, RA CAPITAL MANAGEMENT, L.P. bought 25.72K, RA CAPITAL MANAGEMENT, L.P. bought 1.48K, and RA CAPITAL MANAGEMENT, L.P. bought 7.92K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $26.47 |
| Market Cap | $1.27B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.61 |
| 52-Week Low | $23.00 |
| Volume | 206 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
COAG analyst coverage data. Average price target: $0.00.